 How Can Taiwan's Venture Capital Industry Develop Ethical Decision-Making Mechanisms for Investing in Biotechnology Startups?Tzu-Chun Sheng and Chiu-Ying Chang Advances in Management and Applied Economics, 2025, vol. 15, issue 2, 9 Abstract: This study investigates the ethical challenges faced by Taiwan’s venture capital (VC) industry when investing in biotechnology companies and proposes mechanisms to address these issues. Using a literature review, case analysis, and expert interviews, the study identifies dilemmas such as information asymmetry, uncertainty, and conflicts of interest. Findings reveal that excessive pursuit of profits often leads VC firms to overlook social responsibilities, increasing ethical risks and harming industry reputation. To mitigate this, the study recommends that VC firms establish dedicated ethical committees to audit risks and provide guidance. It also suggests creating investment guidelines to define acceptable practices and integrating ethics, morality, and legal compliance education into the biotechnology sector. These recommendations aim to help Taiwan’s VC industry effectively address ethical challenges, enhance social responsibility, and support sustainable industry growth.  JEL classification numbers: G24, D70, O35. Keywords: Venture capital firms; Biotech start-ups; Ethical decision-making; Expert in-depth interviews. (search for similar items in EconPapers) Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:spt:admaec:v:15:y:2025:i:2:f:15_2_9 Access Statistics for this article More articles in Advances in Management and Applied Economics from SCIENPRESS Ltd |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.